A Cardiovascular and Renal Drugs Advisory Committee to the FDA held a public meeting last week to discuss safety considerations in the development of
Continue Reading FDA Advisory Committee Holds Meeting On Contrast Agents
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation